Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s...
You must be a Standard 1 Year member to access this content.
Cooley advised YH Entertainment on the deal. Sidley acted as Hong Kong legal counsel for the joint sponsors and overall coordinators China Securities (International) Corporate Finance...
You must be a Standard 1 Year member to access this content.
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
Cooley advised M33 Growth on the deal. M33 Growth, a venture and growth-stage investment firm, announced the closing of its third fund at $340 million. Investors in...
You must be a Standard 1 Year member to access this content.
YPOG advised Atomico on the deal. Taylor Wessing advised DeepL. Cooley, GLNS and SSH Rechtsanwälte advised IVP. DeepL, a Cologne, Germany-based artificial intelligence startup that provides...
You must be a Standard 1 Year member to access this content.
Cooley advised Brookfield Growth on the deal. Brookfield Growth, the technology investment arm of Brookfield Asset Management, announced its investment of $25 million in SirionLabs’ Series D...
You must be a Standard 1 Year member to access this content.
Cooley advised Arcadia on the deal. Arcadia, a technology company empowering energy innovators to fight the climate crisis, announced its $125 million in new funding. Magnetar Capital...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
You must be a Standard 1 Year member to access this content.
CMS Carey & Allende and Cooley advised HealthAtom, while Villarino E Ilharreborde and Wilson Sonsini Goodrich & Rosati advised Kayyak Ventures in the transaction. The Chilean...
You must be a Standard 1 Year member to access this content.
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Cooley advised Tmunity on the deal. Tmunity, a clinical-stage biotechnology company, announced its agreement to sell to Kite, a global biopharmaceutical company. The acquisition will provide...
You must be a Standard 1 Year member to access this content.
